Compare INTT & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTT | STIM |
|---|---|---|
| Founded | 1981 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.2M | 120.4M |
| IPO Year | 1997 | 2018 |
| Metric | INTT | STIM |
|---|---|---|
| Price | $10.64 | $2.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $13.50 | $3.00 |
| AVG Volume (30 Days) | 94.9K | ★ 1.2M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $66,801,000.00 | $52,776,000.00 |
| Revenue This Year | $15.82 | $11.10 |
| Revenue Next Year | $9.10 | $11.92 |
| P/E Ratio | $179.83 | ★ N/A |
| Revenue Growth | ★ 66.06 | N/A |
| 52 Week Low | $7.07 | $0.80 |
| 52 Week High | $20.00 | $3.44 |
| Indicator | INTT | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 50.27 |
| Support Level | $10.32 | $2.67 |
| Resistance Level | $11.83 | N/A |
| Average True Range (ATR) | 0.46 | 0.20 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 48.34 | 22.88 |
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.